Steven J. Rice, Chief Administrative Officer at Vir Biotechnology, Inc. (VIR), sold 3 shares at $50.00 ($150) on 2021-06-25, disclosed to the SEC on 2021-06-29.
Scheduled sale ($150) by Chief Administrative Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2023-02-21 | $100K | — | Filing → |
| VIR | SELL | 2022-02-22 | $124K | — | Filing → |
| VIR | SELL | 2021-12-02 | $500K | — | Filing → |